A5078765891- Diabetes Treatment and Management
- Schizophrenia research and treatment
- Inflammatory Bowel Disease
- Microscopic Colitis
- Diverticular Disease and Complications
- Diet and metabolism studies
- Gastric Cancer Management and Outcomes
- Substance Abuse Treatment and Outcomes
- Gastrointestinal motility and disorders
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Pancreatic and Hepatic Oncology Research
- Vibrio bacteria research studies
- Diabetes and associated disorders
- Long-Term Effects of COVID-19
- Regulation of Appetite and Obesity
- Bipolar Disorder and Treatment
- Antibiotic Resistance in Bacteria
- Health Systems, Economic Evaluations, Quality of Life
- Gastrointestinal disorders and treatments
- Musculoskeletal pain and rehabilitation
- Pancreatitis Pathology and Treatment
- Diabetes Management and Research
- Mental Health Treatment and Access
- Spine and Intervertebral Disc Pathology
- Salmonella and Campylobacter epidemiology
Hvidovre Hospital
1997-2025
Copenhagen University Hospital
2018-2025
Bispebjerg Hospital
2021-2025
Rigshospitalet
2017-2020
Capital Region of Denmark
2018-2020
Mental Health Services
2018-2020
University of Copenhagen
2017-2018
Compared with the general population, patients schizophrenia have a 2- to 3-fold higher mortality rate primarily caused by cardiovascular disease. Previous interventions designed counteract antipsychotic-induced weight gain and cardiometabolic disturbances reported limited effects.
The acute symptoms after whiplash traumas can be explained by the neck sprain, but pathogenesis of "late syndrome" and reason why only some people have persistent more than 6 months is still unknown.Thirty-four consecutive cases injury were examined clinically three times; within 14 days, 1 month finally 7 postinjury. In addition, MRI brain cervical spine, neuropsychological tests motor evoked potentials (MEP) done one postinjury repeated months, if abnormalities found.The total recovery...
Abstract Background Despite a growing array of medical treatment options, resection rates for Crohn’s disease (CD) have decreased over time, while re-resection remained stable at approximately one-third in historical cohorts. This study aimed to assess 30-day postoperative outcomes and complication following primary bowel CD patients. Methods encompassed all patients undergoing Eastern Denmark from 2010 2020 (46% the Danish population, n=2,730,000). Clinical characteristics, surgical...
Abstract Background Recent studies suggest that physical activity (PA) may improve the quality of life and relieve fatigue in patients with inflammatory bowel disease (IBD). However, there is no consensus as to what type PA intervention should be offered IBD barriers related stigmatization symptoms calls for an individually tailored approach. We developed a involving patients, health professionals other stakeholders co-creation process. This study aims determine feasibility acceptability...
Treatment with most antipsychotics is associated an increased risk of weight gain and metabolic disturbances. In a randomized trial, we previously demonstrated that 16 weeks glucagon-like peptide-1 receptor agonist liraglutide treatment vs. placebo significantly reduced glucometabolic disturbances body in prediabetic, overweight/obese schizophrenia-spectrum disorder patients treated clozapine or olanzapine. The aim this study was to investigate whether the beneficial effects 16-week...
We describe a ceftriaxone-resistant Salmonella Typhi bacteraemia in pregnant woman returning from family visit Pakistan. Whole genome sequencing confirmed similarity to Pakistani outbreak clone. Pregnancy and unawareness of this delayed appropriate antibiotic therapy. Concurrently, we detected faecal carriage carbapenemase-producing Escherichia coli. Awareness the ongoing should affect empiric treatment typhoid fever hygiene precautions travellers Meropenem may be warranted severe cases.
Objective To assess the prevalence of prediabetes and metabolic abnormalities among overweight or obese clozapine- olanzapine-treated schizophrenia patients, to identify characteristics group with prediabetes. Methods A cross-sectional study assessing presence in patients a body mass index (BMI) ≥27 kg/m 2 . Procedures were part screening process for randomized, placebo-controlled trial evaluating liraglutide vs placebo improving glucose tolerance. For comparison, an age-, sex-, BMI-matched...
Patients with psychiatric disorders have a greater risk of mortality than the general population. Use or abuse substances, including alcohol, play crucial part in this context. Moreover, it is well known that drug use can worsen psychopathology and reduce treatment compliance. However, magnitude these problems among Danish patients has not been studied previously.The aim study to investigate substance Capital Region Denmark.Outpatients from five units were asked complete questionnaire...
Abstract Background The rate of having a resection for patients with Crohn's disease (CD) have decreased over decades, while the rates re-resections seem to been stable around 1/3 in historic cohorts. Re-resection might be influenced by targeted therapies. We aimed investigate re-resection and risk recurrence contemporary cohort effect medical treatment on these parameters. Methods This population-based included all CD undergoing primary intestinal between 2010 2020 Eastern Denmark,...
Abstract Background We previously demonstrated that the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide significantly reduced glucometabolic disturbances and body weight vs placebo in prediabetic, overweight, or obese schizophrenia-spectrum disorder patients treated with clozapine olanzapine. Here, we aimed to identify potential biomarkers of prediabetes GLP-1RA-induced effects on glucose tolerance schizophrenia Methods Multiplexed immunoassays were used measure 8 proteins...
Despite advances in the medical treatment of Crohn's disease [CD], many patients will still need bowel resections and face subsequent risk recurrence re-resection. We describe contemporary re-resection rates identify disease-modifying factors for conducted a retrospective, population-based, individual patient-level data cohort study covering 47.4% Danish population, including all CD who underwent primary resection between 2010 2020. Among 631 resected patients, 24.5% second resection, 5.3%...